A previous recommendation suggests that stool be cultured for mycobacteria only if the smear is positive. We have correlated smear and culture results of 2,176 stool specimens submitted for mycobacterial culture. The sensitivity, specificity, and positive and negative predictive values for smears to predict culture results are 34, 99, 90, and 87%, respectively. We recommend that the stool smear not be used as a screening technique to decide which specimens from at-risk patients should be cultured because it lacks the necessary sensitivity.
It is thought that Mycobacterium avium complex (MAC) is acquired from the environment and colonizes either the respiratory or gastrointestinal tract before disseminating in human immunodeficiency virus (HIV)-infected patients (4, 6) . Disseminated MAC is associated with significant morbidity and shortened survival times (4, 6, 7, 10) . Although it is controversial (4, 5, 16, 17) , data suggest that therapy for disseminated MAC improves patient symptoms (2, 8, 11, 18) and survival rates (6) . These findings have prompted suggestions that prophylaxis, which helps in other AIDS-related opportunistic infections, may prevent or delay disseminated MAC infection (4, 7, 18) . Whether the issue is the study of the natural history of MAC acquisition and dissemination, the response to therapy, or the success of prophylaxis, laboratory methods of detection need to be adequately sensitive.
The Manual of Clinical Microbiology recommends that if acid-fast bacilli are not observed in unprocessed stool, then the specimen need not be cultured (15) . This suggestion is based on the data of Kiehn et al. (13) . In that study, direct smears with acid-fast staining were performed on 17 specimens. All 12 smear-positive stools grew MAC; the 5 smearnegative stools were not cultured. More-recent data from the same group showed that 21 of 31 MAC culture-positive stool specimens (68%) were smear negative (12) . We are unaware of data on a large number of stool specimens which have had both smears and cultures for mycobacteria performed. We have, therefore, analyzed our data to find out how sensitive the acid-fast stain is in predicting stool mycobacterial culture results.
Data from three institutions on three continents which perform smears and cultures on all stool specimens submitted for mycobacterial culture were analyzed. Duke University Medical Center (DUMC), Durham, N.C., is a tertiary care university medical center serving an HIV-AIDS clinic caring for approximately 1,100 patients. The National Center for Mycobacteria (NCM), Zurich, Switzerland, is a refer-* Corresponding author. DUMC and NCM is shown in Table 2 . Forty of 65 (62%) culture-positive specimens had a negative smear, 9 (14%) grew in BACTEC 12B broth only, suggesting low numbers, and another 16 (25%) had fewer than 11 colonies, but 4 smear-negative specimens grew more than 100 colonies of MAC. Seventeen of the 30 specimens (57%) with positive smears grew more than 100 colonies of either MAC or M. tuberculosis. Similar results were observed at FIID, where only 221 of 1,552 specimens (14%) with a negative smear yielded mycobacteria versus 107 of 118 specimens (91%) with a positive smear.
The question remains as to the clinical usefulness of performing smears for acid-fast bacilli in fecal specimens from HIV-infected or AIDS patients. At FIID, MAC was cultured from smear-negative stools of 27 patients on one or more occasions prior to its recovery from one or more smear-positive fecal specimens. On the other hand, in 13 patients the first smear-positive, MAC-positive fecal specimen was not preceded by a smear-negative, MAC culturepositive specimen. Although the routine examination of fecal smears for acid-fast bacilli may have clinical utility, such utility was not examined in this study. There are few data on the frequency and quantity of mycobacteria in stools from healthy populations. Mycobacteria have been isolated in low numbers (one to three colonies per processed stool specimen) from the stools of approximately 50% of healthy individuals (14) . Twenty percent of isolates were MAC, but it is not known whether these are M. avium or M. intracellulare (14) . At FIID, however, only 20 of 1,100 refugees (2%) screened by the same methods used for HIV-infected or AIDS patients had mycobacteria recovered from their stools (3). Twenty-nine of the 65 culture-positive patients (45%) who had growth quantified had either c10 colonies or growth in only the BACTEC system. The relevance of such numbers is unclear and needs prospective study.
The presence of acid-fast bacilli in the fecal smear and the (12) . In their series of 31 MAC culture-positive stool specimens, the smear had a sensitivity of 32%; our result was 34%. These data suggest that the fecal smear result should not determine whether a culture for mycobacteria should be performed.
